The DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.
Hypertriglyceridemia, insulin resistance, and the metabolic syndrome
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Prediction of coronary heart disease using risk factor categories
Wilson, P. W. F., D’Agostino, R. B., Levy, D., Belanger, A. M., Silbershatz, H., & Kannel, W. B. (1998) · Circulation · doi:10.1161/01.cir.97.18.1837 · Cited by 9,581
Quantification of coronary artery calcium using ultrafast computed tomography
Agatston, A. S., Janowitz, W. R., Hildner, F. J., Zusmer, N. R., Viamonte, M., & Detrano, R. (1990) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(90)90282-t · Cited by 7,786
Reaven, G. M., Lithell, H., & Landsberg, L. (1996) · New England Journal of Medicine · doi:10.1056/nejm199602083340607 · Cited by 1,435
Perseghin, G., Price, T. B., Petersen, K. F., Roden, M., Cline, G. W., Gerow, K., Rothman, D. L., & Shulman, G. I. (1996) · New England Journal of Medicine · doi:10.1056/nejm199610313351804 · Cited by 699
Influence of body fat distribution on free fatty acid metabolism in obesity.
Jensen, M. D., Haymond, M. W., Rizza, R. A., Cryer, P. E., & Miles, J. M. (1989) · Journal of Clinical Investigation · doi:10.1172/jci113997 · Cited by 683
Hypertriglyceridemia, atherogenic dyslipidemia, and the metabolic syndrome
Grundy, S. M. (1998) · The American Journal of Cardiology · doi:10.1016/s0002-9149(98)00033-2 · Cited by 525
Self-citationGinsberg, H. N., Le, N. A., Goldberg, I. J., Gibson, J. C., Rubinstein, A., Wang-Iverson, P., Norum, R., & Brown, W. V. (1986) · Journal of Clinical Investigation · doi:10.1172/jci112713 · Cited by 424
The Insulin Resistance—Dyslipidemic Syndrome of Visceral Obesity: Effect on Patients' Risk
Després, J. (1998) · Obesity Research · doi:10.1002/j.1550-8528.1998.tb00683.x · Cited by 261
Troglitazone-Induced Hepatic Failure Leading to Liver Transplantation: A Case Report
Neuschwander-Tetri, B. A., Isley, W. L., Oki, J. C., Ramrakhiani, S., Quiason, S. G., Phillips, N. J., & Brunt, E. M. (1998) · Annals of Internal Medicine · doi:10.7326/0003-4819-129-1-199807010-00009 · Cited by 195
Eriksson, P., Nilsson, L., Karpe, F., & Hamsten, A. (1998) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.18.1.20 · Cited by 187
Research works printed but not linked: 49
- Grundy, 1990, Coronary heart disease in high-risk populations, Eur Heart J, 11, 462, 10.1093/oxfordjournals.eurheartj.a059730 · DOI
- Williams, 1992, Familial dyslipidaemic hypertension and other multiple metabolic syndromes, Ann Med, 24, 469, 10.3109/07853899209166998 · DOI
- Juhan-Vague, 1991, Increased plasma plasminogen activator inhibitor 1 levels. A possible link between insulin resistance and atherothrombosis, Diabetologia, 34, 457, 10.1007/BF00403280 · DOI · Paper page
- Reaven, 1995, Pathophysiology of insulin resistance in human disease, Physiol Rev, 75, 473, 10.1152/physrev.1995.75.3.473 · DOI · Paper page
- DeFronzo, 1991, Insulin resistance. A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia and atherosclerotic cardiovascular disease, Diabetes Care, 14, 173, 10.2337/diacare.14.3.173 · DOI · Paper page
- Garg, 1994, Effects of varying carbohydrate content of diet in patients with noninsulin-dependent diabetes mellitus, JAMA, 271, 1421, 10.1001/jama.1994.03510420053034 · DOI · Paper page
- Rowe, 1983, Characterization of the insulin resistance of aging, J Clin Invest, 71, 1581, 10.1172/JCI110914 · DOI · Paper page
- Walker, 1996, Abnormal glucocorticoid activity in subjects with risk factors for cardiovascular disease, Endocr Res, 22, 701, 10.1080/07435809609043765 · DOI
- Dunaif, 1997, Insulin resistance and the polycystic ovary syndrome, Endocr Rev, 18, 774
- Kissebah, 1976, Role of insulin resistance in adipose tissue and liver in the pathogenesis of endogenous hypertriglyceridemia in man, Diabetologia, 12, 563, 10.1007/BF01220632 · DOI · Paper page
- Steiner, 1994, Hyperinsulinaemia and hypertriglyceridaemia, J Intern Med Suppl, 736, 23
- Mostaza, 1998, Abnormal metabolism of free fatty acids in hypertriglyceridaemic men, J Intern Med, 243, 265, 10.1046/j.1365-2796.1998.00298.x · DOI
- Windler, 1985, Inhibitory effects of C apolipoproteins from rats and humans on the uptake of triglyceride-rich lipoproteins and their remnants by the perfused rat liver, J Lipid Res, 26, 556, 10.1016/S0022-2275(20)34342-X · DOI · Paper page
- Haffner, 1995, A preponderance of small dense LDL is associated with specific insulin, proinsulin and the components of the insulin resistance syndrome in non-diabetic subjects, Diabetologia, 38, 1328, 10.1007/BF00401766 · DOI
- Karhapaa, 1994, Isolated low HDL cholesterol. An insulin-resistance state, Diabetes, 43, 411, 10.2337/diab.43.3.411 · DOI
- Edelson, 1993, Insulin resistance in hypertension, Am J Med Sci, 306, 345, 10.1097/00000441-199311000-00014 · DOI
- Sowers, 1990, Insulin resistance and hypertension, Mol Cell Endocrinol, 74, C87, 10.1016/0303-7207(90)90110-T · DOI
- Hopkins, 1996, Hypertension, dyslipidemia, and insulin resistance, Curr Opin Lipidol, 7, 241, 10.1097/00041433-199608000-00011 · DOI
- Williams, 1988, Familial dyslipidemic hypertension. Evidence from 58 Utah families for a syndrome present in approximately 12% of patients with essential hypertension, JAMA, 259, 3579, 10.1001/jama.1988.03720240041032 · doi:10.1001/jama.1988.03720240041032 · Paper page
- Eriksson, 1992, Metabolic disturbances in hypertension: results from the population study “men born in 1913.”, J Intern Med, 232, 389, 10.1111/j.1365-2796.1992.tb00604.x · DOI
- Miller, 1994, Lipoproteins and the haemostatic system in atherothrombotic disorders, Baillieres Clin Haematol, 7, 713, 10.1016/S0950-3536(05)80105-2 · DOI
- Hiraga, 1996, Hypertriglyceridemia, but not hypercholesterolemia, is associated with the alterations of fibrinolytic system, Horm Metab Res, 28, 603, 10.1055/s-2007-979862 · DOI
- Ohni, 1995, Serum triglycerides and blood coagulation factors VII and X, and plasminogen activator inhibitor-1, J Atheroscler Thromb, 2, S41, 10.5551/jat1994.2.Supplement1_S41 · DOI
- Asplund-Carlson, 1993, Relationship between plasma plasminogen activator inhibitor-1 activity and VLDL triglyceride concentration, insulin levels and insulin sensitivity, Diabetologia, 36, 817, 10.1007/BF00400356 · DOI
- Schutz, 1993, Investigations into the haemorheological significance of postprandial and fasting hypertriglyceridaemia, Eur J Clin Invest, 23, 270, 10.1111/j.1365-2362.1993.tb00773.x · doi:10.1111/j.1365-2362.1993.tb00773.x
- Potter van Loon, 1993, The cardiovascular risk factor plasminogen activator inhibitor type 1 is related to insulin resistance, Metabolism, 42, 945, 10.1016/0026-0495(93)90005-9 · DOI · Paper page
- Mykkanen, 1994, Insulin sensitivity is not an independent determinant of plasma plasminogen activator inhibitor-1 activity, Arterioscler Thromb, 14, 1264, 10.1161/01.ATV.14.8.1264 · DOI
- Vague, 1995, Hypofibrinolysis and the insulin resistance syndrome, Int J Obes Relat Metab Disord, 19, S11
- Lindahl, 1996, Insulin resistance syndrome and fibrinolytic activity, Int J Epidemiol, 25, 291, 10.1093/ije/25.2.291 · DOI
- Juhan-Vague, 1997, PAI-1, obesity, insulin resistance and risk of cardiovascular events, Thromb Haemost, 78, 656, 10.1055/s-0038-1657607 · DOI · Paper page
- Colman, 1995, Weight loss reduces abdominal fat and improves insulin action in middle-aged and older men with impaired glucose tolerance, Metabolism, 44, 1502, 10.1016/0026-0495(95)90153-1 · DOI
- Ikeda, 1996, Improvement of insulin sensitivity contributes to blood pressure reduction after weight loss in hypertensive subjects with obesity, Hypertension, 27, 1180, 10.1161/01.HYP.27.5.1180 · DOI
- Bosello, 1997, The benefits of modest weight loss in type II diabetes, Int J Obes Relat Metab Disord, 21, S10
- Weinstock, 1998, Diet and exercise in the treatment of obesity, Arch Intern Med, 158, 2477, 10.1001/archinte.158.22.2477 · DOI
- Dengel, 1998, Improvements in blood pressure, glucose metabolism, and lipoprotein lipids after aerobic exercise plus weight loss in obese, hypertensive middle-aged men, Metabolism, 47, 1075, 10.1016/S0026-0495(98)90281-5 · DOI
- Markovic, 1998, The determinants of glycemic responses to diet restriction and weight loss in obesity and NIDDM, Diabetes Care, 21, 687, 10.2337/diacare.21.5.687 · DOI · Paper page
- Prigeon, 1995, Changes in insulin sensitivity, glucose effectiveness, and β-cell function in regularly exercising subjects, Metabolism, 44, 1259, 10.1016/0026-0495(95)90026-8 · DOI · Paper page
- Dengel, 1996, Distinct effects of aerobic exercise training and weight loss on glucose homeostasis in obese sedentary men, J Appl Physiol, 81, 318, 10.1152/jappl.1996.81.1.318 · DOI · Paper page
- Etgen, 1997, Exercise training reverses insulin resistance in muscle by enhanced recruitment of GLUT-4 to the cell surface, Am J Physiol, 272, E864
- Brown, 1997, Improvement of insulin sensitivity by short-term exercise training in hypertensive African American women, Hypertension, 30, 1549, 10.1161/01.HYP.30.6.1549 · DOI
- Bonen, 1998, Glucose tolerance is improved after low- and high-intensity exercise in middle-age men and women, Can J Appl Physiol, 23, 583, 10.1139/h98-033 · DOI
- Goodyear, 1998, Exercise, glucose transport, and insulin sensitivity, Annu Rev Med, 49, 235, 10.1146/annurev.med.49.1.235 · DOI · Paper page
- Mayer-Davis, 1998, Intensity and amount of physical activity in relation to insulin sensitivity, JAMA, 279, 669, 10.1001/jama.279.9.669 · DOI · Paper page
- Henry, 1997, Thiazolidinediones, Endocrinol Metab Clin North Am, 26, 553, 10.1016/S0889-8529(05)70267-X · DOI
- Gitlin, 1998, Two cases of severe clinical and histologic hepatotoxicity associated with troglitazone, Ann Intern Med, 129, 36, 10.7326/0003-4819-129-1-199807010-00008 · DOI · Paper page
- Vella, 1998, Fatal hepatotoxicity associated with troglitazone, Ann Intern Med, 129, 1080, 10.7326/0003-4819-129-12-199812150-00032 · DOI
- Manninen, 1989, Relation between baseline lipid and lipoprotein values and the incidence of coronary heart disease in the Helsinki Heart Study, Am J Cardiol, 63, 42H, 10.1016/0002-9149(89)90115-X · DOI
- Carlson, 1988, Reduction of mortality in the Stockholm ischaemic heart disease secondary prevention study to combined treatment with clofibrate and nicotinic acid, Acta Med Scand, 223, 405, 10.1111/j.0954-6820.1988.tb15891.x · DOI · Paper page
- Vega, 1990, Management of primary mixed hyperlipidemia with lovastatin, Arch Intern Med, 150, 1313, 10.1001/archinte.1990.00390180119022 · DOI
Cited by
Ford, E. S., Giles, W. H., & Dietz, W. H. (2002) · JAMA · doi:10.1001/jama.287.3.356 · Cited by 6,698
Park, Y.-W., Zhu, S., Palaniappan, L., Heshka, S., Carnethon, M. R., & Heymsfield, S. B. (2003) · Archives of Internal Medicine · doi:10.1001/archinte.163.4.427 · Cited by 2,074
The PPARs: From Orphan Receptors to Drug Discovery
Willson, T. M., Brown, P. J., Sternbach, D. D., & Henke, B. R. (2000) · Journal of Medicinal Chemistry · doi:10.1021/jm990554g · Cited by 1,816
Authors/Task Force Members, Ryden, L., Standl, E., Bartnik, M., Van den Berghe, G., Betteridge, J., de Boer, M.-J., Cosentino, F., Jonsson, B., Laakso, M., et al. (2006) · European Heart Journal · doi:10.1093/eurheartj/ehl260 · Cited by 1,647
Abdominal obesity and the metabolic syndrome: contribution to global cardiometabolic risk
Després, J.-P., Lemieux, I., Bergeron, J., Pibarot, P., Mathieu, P., Larose, E., Rodés-Cabau, J., Bertrand, O. F., & Poirier, P. (2008) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.107.159228 · Cited by 1,589
Metadata
- Authors
- Grundy, S. M.
- Venue
- The American Journal of Cardiology
- Publisher
- Elsevier BV
- Published
- 1999-05
- Volume
- 83
- Issue
- 9
- Pages
- 25-29
- ISSN
- 0002-9149 (ISSN-L)
- OpenAlex
- W2060409824
- Cited by
- 610
- References
- 11
- FWCI
- 14.26
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Hypertriglyceridemia, insulin resistance, and the metabolic syndrome. https://app.cochat.ai/papers/10.1016/s0002-9149(99)00211-8
- The paper
- Grundy, S. M. (1999). Hypertriglyceridemia, insulin resistance, and the metabolic syndrome. The American Journal of Cardiology. https://doi.org/10.1016/s0002-9149(99)00211-8
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.